The AI-driven workflow of CBLB inhibitor design and representative novel scaffolds (IMAGE)

InSilico Medicine

The AI-driven workflow of CBLB inhibitor design and representative novel scaffolds

Caption

The research started with ligand-based design using Chemistry42, Insilico's generative AI platform for molecule generation and optimization, hoping to obtain novel, improved core structures.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.